Chemerin: A potential endocrine link between obesity and type 2 diabetes

Endocrine

Volumn 42, Issue 2, 2012, Pages 243-251

  Roman, Alexandra A ^a   Parlee, Sebastian D ^a   Sinal, Christopher J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adipokine; Chemerin; CMKLR1; Diabetes; Inflammation; Insulin resistance; Obesity

Indexed keywords

C REACTIVE PROTEIN; CHEMERIN; CHEMOKINE LIKE RECEPTOR 1; G PROTEIN COUPLED RECEPTOR; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOGENESIS; CYTOKINE RELEASE; DISEASE ASSOCIATION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC SYNDROME X; NEUTROPHIL CHEMOTAXIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; WHITE ADIPOSE TISSUE;

EID: 84867400129     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9698-8     Document Type: Review

References (76)

1. National Institute of Health, Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes. Res. 6(Suppl 2), 51S-209S (1998)
2. H. Shamseddeen, J.Z. Getty, I.N. Hamdallah, M.R. Ali, Epidemiology and economic impact of obesity and type 2 diabetes. Surg. Clin. North. Am. 91(6), 1163-1172 (2011)
3. P.G. Kopelman, Obesity as a medical problem. Nature 404(6778), 635-643 (2000)
4. O.T. Hardy, M.P. Czech, S. Corvera, What causes the insulin resistance underlying obesity? Curr. Opin. Endocrinol. Diabetes. Obes. 19(2), 81-87 (2012)
5. J. Conde, M. Scotece, R. Gomez, V. Lopez, J.J. Gomez-Reino, F. Lago, O. Gualillo, Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. BioFactors 37(6), 413-420 (2011)
6. E.E. Kershaw, J.S. Flier, Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89(6), 2548-2556 (2004)
7. S.P. Poulos, D.B. Hausman, G.J. Hausman, The development and endocrine functions of adipose tissue. Mol. Cell. Endocrinol. 323(1), 20-34 (2010)
8. N. Ouchi, J.L. Parker, J.J. Lugus, K. Walsh, Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11(2), 85-97 (2011)
9. K. Brochu-Gaudreau, C. Rehfeldt, R. Blouin, V. Bordignon, B.D. Murphy, M.F. Palin, Adiponectin action from head to toe. Endocrine 37(1), 11-32 (2010)
10. M. Bluher, Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine 41(2), 176-182 (2012)
11. M. Pardo, A. Roca-Rivada, L.M. Seoane, F.F. Casanueva, Obesidomics: contribution of adipose tissue secretome analysis to obesity research. Endocrine 41(3), 374-383 (2012)
12. I. Castan-Laurell, C. Dray, C. Attane, T. Duparc, C. Knauf, P. Valet, Apelin, diabetes, and obesity. Endocrine 40(1), 1-9 (2011)
13. S. Baldasseroni, E. Mannucci, C. Di Serio, F. Orso, N. Bartoli, E. Mossello, A. Foschini, M. Monami, P. Valoti, S. Fumagalli, C. Colombi, S. Pellerito, G. Gensini, N. Marchionni, F. Tarantini, Resistin level in coronary artery disease and heart failure: the central role of kidney function. J Cardiovasc Med (Hagerstown) (2012)
14. G.S. Hotamisligil, P. Arner, J.F. Caro, R.L. Atkinson, B.M. Spiegelman, Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95(5), 2409-2415 (1995)
15. M. Okamoto, M. Ohara-Imaizumi, N. Kubota, S. Hashimoto, K. Eto, T. Kanno, T. Kubota, M. Wakui, R. Nagai, M. Noda, S. Nagamatsu, T. Kadowaki, Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. Diabetologia 51(5), 827-835 (2008)
16. H. Sell, J. Eckel, Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation? Proc. Nutr. Soc. 68(4), 378-384 (2009)
17. R. Coppari, M. Ichinose, C.E. Lee, A.E. Pullen, C.D. Kenny, R.A. McGovern, V. Tang, S.M. Liu, T. Ludwig, S.C. Chua Jr, B.B. Lowell, J.K. Elmquist, The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab. 1(1), 63-72 (2005)
18. M. Yang, G. Yang, J. Dong, Y. Liu, H. Zong, H. Liu, G. Boden, L. Li, Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. J. Investig. Med. 58(7), 883-886 (2010)
19. J. Hirosumi, G. Tuncman, L. Chang, C.Z. Gorgun, K.T. Uysal, K. Maeda, M. Karin, G.S. Hotamisligil, A central role for JNK in obesity and insulin resistance. Nature 420(6913), 333-336 (2002)
20. S.I. Itani, N.B. Ruderman, F. Schmieder, G. Boden, Lipidinduced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51(7), 2005-2011 (2002)
21. M.C. Arkan, A.L. Hevener, F.R. Greten, S. Maeda, Z.W. Li, J.M. Long, A. Wynshaw-Boris, G. Poli, J. Olefsky, M. Karin, IKKbeta links inflammation to obesity-induced insulin resistance. Nat. Med. 11(2), 191-198 (2005)
22. T.J. Guzik, D. Mangalat, R. Korbut, Adipocytokines-novel link between inflammation and vascular function? J. Physiol. Pharmacol. 57(4), 505-528 (2006)
23. T. Yamauchi, Y. Nio, T. Maki, M. Kobayashi, T. Takazawa, M. Iwabu, M. Okada-Iwabu, S. Kawamoto, N. Kubota, T. Kubota, Y. Ito, J. Kamon, A. Tsuchida, K. Kumagai, H. Kozono, Y. Hada, H. Ogata, K. Tokuyama, M. Tsunoda, T. Ide, K. Murakami, M. Awazawa, I. Takamoto, P. Froguel, K. Hara, K. Tobe, R. Nagai, K. Ueki, T. Kadowaki, Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13(3), 332-339 (2007)
24. T.P. Combs, U.B. Pajvani, A.H. Berg, Y. Lin, L.A. Jelicks, M. Laplante, A.R. Nawrocki, M.W. Rajala, A.F. Parlow, L. Cheeseboro, Y.Y. Ding, R.G. Russell, D. Lindemann, A. Hartley, G.R. Baker, S. Obici, Y. Deshaies, M. Ludgate, L. Rossetti, P.E. Scherer, A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145(1), 367-383 (2004)
25. A. Petrone, S. Zavarella, A. Caiazzo, G. Leto, M. Spoletini, S. Potenziani, J. Osborn, A. Vania, R. Buzzetti, The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity. Obesity (Silver Spring) 14(9), 1498-1504 (2006)
26. S.M. Ruchat, R.J. Loos, T. Rankinen, M.C. Vohl, S.J. Weisnagel, J.P. Despres, C. Bouchard, L. Perusse, Associations between glucose tolerance, insulin sensitivity and insulin secretion phenotypes and polymorphisms in adiponectin and adiponectin receptor genes in the Quebec Family Study. Diabet. Med. 25(4), 400-406 (2008)
27. M.C. Ernst, C.J. Sinal, Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol. Metab. 21(11), 660-667 (2010)
28. D. Stejskal, M. Karpisek, Z. Hanulova, M. Svestak, Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-a pilot study. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 152(2), 217-221 (2008)
29. J. Weigert, M. Neumeier, J. Wanninger, M. Filarsky, S. Bauer, R. Wiest, S. Farkas, M.N. Scherer, A. Schaffler, C. Aslanidis, J. Scholmerich, C. Buechler, Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin. Endocrinol. (Oxf) 72(3), 342-348 (2010)
30. D. M. Ouwens, M. Bekaert, B. Lapauw, Y. V. Nieuwenhove, S. Lehr, S. Hartwig, P. Calders, J. M. Kaufman, H. Sell, J. Eckel, J. B. Ruige, Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome. Arch Physiol Biochem (2012) [epub ahead of print]
31. M. Bluher, A. Rudich, N. Kloting, R. Golan, Y. Henkin, E. Rubin, D. Schwarzfuchs, Y. Gepner, M.J. Stampfer, M. Fiedler, J. Thiery, M. Stumvoll, I. Shai, Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 35(2), 342-349 (2012)
32. R. Chakaroun, M. Raschpichler, N. Kloting, A. Oberbach, G. Flehmig, M. Kern, M.R. Schon, E. Shang, T. Lohmann, M. Dressler, M. Fasshauer, M. Stumvoll, M. Bluher, Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 61(5), 706-714 (2011)
33. Verrijn Stuart, Altered plasma adipokine levels and in vitro adipocyte differentiation in pediatric type 1 diabetes. J. Clin. Endocrinol. Metab. 97(2), 463-472 (2012)
34. Y.J. Hah, N.K. Kim, M.K. Kim, H.S. Kim, S.H. Hur, H.J. Yoon, Y.N. Kim, K.G. Park, Relationship between chemerin levels and cardiometabolic parameters and degree of coronary stenosis in Korean patients with coronary artery disease. Diabet. Metab. J. 35(3), 248-254 (2011)
35. H.O. El-Mesallamy, M.O. El-Derany, N.M. Hamdy, Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet. Med. 28(10), 1194-1200 (2011)
36. M. Lehrke, A. Becker, M. Greif, R. Stark, R.P. Laubender, F. von Ziegler, C. Lebherz, J. Tittus, M. Reiser, C. Becker, B. Goke, A.W. Leber, K.G. Parhofer, U.C. Broedl, Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur. J. Endocrinol. 161(2), 339-344 (2009)
37. K. Bozaoglu, K. Bolton, J. McMillan, P. Zimmet, J. Jowett, G. Collier, K. Walder, D. Segal, Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148(10), 4687-4694 (2007)
38. C. Ress, A. Tschoner, J. Engl, A. Klaus, H. Tilg, C.F. Ebenbichler, J.R. Patsch, S. Kaser, Effect of bariatric surgery on circulating chemerin levels. Eur. J. Clin. Invest. 40(3), 277-280 (2010)
39. H. Sell, A. Divoux, C. Poitou, A. Basdevant, J.L. Bouillot, P. Bedossa, J. Tordjman, J. Eckel, K. Clement, Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J. Clin. Endocrinol. Metab. 95(6), 2892-2896 (2010)
40. B.K. Tan, J. Chen, S. Farhatullah, R. Adya, J. Kaur, D. Heutling, K.C. Lewandowski, J.P. O'Hare, H. Lehnert, H.S. Randeva, Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 58(9), 1971-1977 (2009)
41. S. Nagpal, S. Patel, H. Jacobe, D. DiSepio, C. Ghosn, M. Malhotra, M. Teng, M. Duvic, R.A. Chandraratna, Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J. Invest. Dermatol. 109(1), 91-95 (1997)
42. V. Wittamer, J.D. Franssen, M. Vulcano, J.F. Mirjolet, E. Le Poul, I. Migeotte, S. Brezillon, R. Tyldesley, C. Blanpain, M. Detheux, A. Mantovani, S. Sozzani, G. Vassart, M. Parmentier, D. Communi, Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med. 198(7), 977-985 (2003)
43. K.B. Goralski, T.C. McCarthy, E.A. Hanniman, B.A. Zabel, E.C. Butcher, S.D. Parlee, S. Muruganandan, C.J. Sinal, Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J. Biol. Chem. 282(38), 28175-28188 (2007)
44. S. Muruganandan, A.A. Roman, C.J. Sinal, Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J. Bone Miner. Res. 25(2), 222-234 (2010)
45. S. Muruganandan, S.D. Parlee, J.L. Rourke, M.C. Ernst, K.B. Goralski, C.J. Sinal, Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis. J. Biol. Chem. 286(27), 23982-23995 (2011)
46. B.A. Zabel, S. Nakae, L. Zuniga, J.Y. Kim, T. Ohyama, C. Alt, J. Pan, H. Suto, D. Soler, S.J. Allen, T.M. Handel, C.H. Song, S.J. Galli, E.C. Butcher, Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgEmediated passive cutaneous anaphylaxis. J. Exp. Med. 205(10), 2207-2220 (2008)
47. G. Barnea, W. Strapps, G. Herrada, Y. Berman, J. Ong, B. Kloss, R. Axel, K.J. Lee, The genetic design of signaling cascades to record receptor activation. Proc. Natl. Acad. Sci. USA 105(1), 64-69 (2008)
48. X.Y. Du, B.A. Zabel, T. Myles, S.J. Allen, T.M. Handel, P.P. Lee, E.C. Butcher, L.L. Leung, Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets. J. Biol. Chem. 284(2), 751-758 (2009)
49. V. Wittamer, B. Bondue, A. Guillabert, G. Vassart, M. Parmentier, D. Communi, Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J. Immunol. 175(1), 487-493 (2005)
50. A. Guillabert, V. Wittamer, B. Bondue, V. Godot, V. Imbault, M. Parmentier, D. Communi, Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation. J. Leukoc. Biol. 84(6), 1530-1538 (2008)
51. H. John, J. Hierer, O. Haas, W.G. Forssmann, Quantification of angiotensin-converting-enzyme-mediated degradation of human chemerin 145-154 in plasma by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. Anal. Biochem. 362(1), 117-125 (2007)
52. B.A. Zabel, S.J. Allen, P. Kulig, J.A. Allen, J. Cichy, T.M. Handel, E.C. Butcher, Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J. Biol. Chem. 280(41), 34661-34666 (2005)
53. V. Wittamer, F. Gregoire, P. Robberecht, G. Vassart, D. Communi, M. Parmentier, The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J. Biol. Chem. 279(11), 9956-9962 (2004)
54. W. Meder, M. Wendland, A. Busmann, C. Kutzleb, N. Spodsberg, H. John, R. Richter, D. Schleuder, M. Meyer, W.G. Forssmann, Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett. 555(3), 495-499 (2003)
55. Y. Yamaguchi, X.Y. Du, L. Zhao, J. Morser, L.L. Leung, Proteolytic cleavage of chemerin protein is necessary for activation to the active form, Chem157S, which functions as a signaling molecule in glioblastoma. J. Biol. Chem. 286(45), 39510-39519 (2011)
56. L. Zhao, Y. Yamaguchi, S. Sharif, X.Y. Du, J.J. Song, D.M. Lee, L.D. Recht, W.H. Robinson, J. Morser, L.L. Leung, Chemerin158 K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma. J. Biol. Chem. 286(45), 39520-39527 (2011)
57. B.A. Zabel, A.M. Silverio, E.C. Butcher, Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J. Immunol. 174(1), 244-251 (2005)
58. W. Vermi, E. Riboldi, V. Wittamer, F. Gentili, W. Luini, S. Marrelli, A. Vecchi, J.D. Franssen, D. Communi, L. Massardi, M. Sironi, A. Mantovani, M. Parmentier, F. Facchetti, S. Sozzani, Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 201(4), 509-515 (2005)
59. S. Parolini, A. Santoro, E. Marcenaro, W. Luini, L. Massardi, F. Facchetti, D. Communi, M. Parmentier, A. Majorana, M. Sironi, G. Tabellini, A. Moretta, S. Sozzani, The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109(9), 3625-3632 (2007)
60. R. Hart, D.R. Greaves, Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J. Immunol. 185(6), 3728-3739 (2010)
61. M. Kukla, K. Zwirska-Korczala, A. Gabriel, M. Waluga, I. Warakomska, B. Szczygiel, A. Berdowska, W. Mazur, E. Wozniak-Grygiel, W. Kryczka, Chemerin, vaspin and insulin resistance in chronic hepatitis C. J. Viral. Hepat. 17(9), 661-667 (2010)
62. H. Nakajima, K. Nakajima, Y. Nagano, M. Yamamoto, M. Tarutani, M. Takahashi, Y. Takahashi, S. Sano, Circulating level of chemerin is upregulated in psoriasis. J. Dermatol. Sci. 60(1), 45-47 (2010)
63. M. Arita, F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N.A. Petasis, C.N. Serhan, Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201(5), 713-722 (2005)
64. M. Wan, C. Godson, P.J. Guiry, B. Agerberth, J.Z. Haeggstrom, Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counter-regulated by lipoxin A4 and resolvin E1. FASEB J. 25(5), 1697-1705 (2011)
65. M. Arita, T. Ohira, Y.P. Sun, S. Elangovan, N. Chiang, C.N. Serhan, Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 178(6), 3912-3917 (2007)
66. J.L. Cash, R. Hart, A. Russ, J.P. Dixon, W.H. Colledge, J. Doran, A.G. Hendrick, M.B. Carlton, D.R. Greaves, Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med. 205(4), 767-775 (2008)
67. J.L. Cash, A.R. Christian, D.R. Greaves, Chemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent manner. J. Immunol. 184(9), 5315-5324 (2010)
68. S. Luangsay, V. Wittamer, B. Bondue, O. De Henau, L. Rouger, M. Brait, J.D. Franssen, P. de Nadai, F. Huaux, M. Parmentier, Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J. Immunol. 183(10), 6489-6499 (2009)
69. K. Shimamura, M. Matsuda, Y. Miyamoto, R. Yoshimoto, T. Seo, S. Tokita, Identification of a stable chemerin analog with potent activity toward ChemR23. Peptides 30(8), 1529-1538 (2009)
70. M.C. Ernst, I.D. Haidl, L.A. Zuniga, H.J. Dranse, J.L. Rourke, B.A. Zabel, E.C. Butcher, C.J. Sinal, Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology 153(2), 672-682 (2012)
71. S. Kralisch, S. Weise, G. Sommer, J. Lipfert, U. Lossner, M. Bluher, M. Stumvoll, M. Fasshauer, Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro. Regul. Pept. 154(1-3), 102-106 (2009)
72. M. Takahashi, Y. Takahashi, K. Takahashi, F.N. Zolotaryov, K.S. Hong, R. Kitazawa, K. Iida, Y. Okimura, H. Kaji, S. Kitazawa, M. Kasuga, K. Chihara, Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett. 582(5), 573-578 (2008)
73. H. Sell, J. Laurencikiene, A. Taube, K. Eckardt, A. Cramer, A. Horrighs, P. Arner, J. Eckel, Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 58(12), 2731-2740 (2009)
74. M.C. Ernst, M. Issa, K.B. Goralski, C.J. Sinal, Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 151(5), 1998-2007 (2010)
75. M. Takahashi, Y. Okimura, G. Iguchi, H. Nishizawa, M. Yamamoto, K. Suda, R. Kitazawa, W. Fujimoto, K. Takahashi, F.N. Zolotaryov, K.S. Hong, H. Kiyonari, T. Abe, H. Kaji, S. Kitazawa, M. Kasuga, K. Chihara, Y. Takahashi, Chemerin regulates beta-cell function in mice. Sci. Rep. 1, 123 (2011)
76. Q. Yan, Y. Zhang, J. Hong, W. Gu, M. Dai, J. Shi, Y. Zhai, W. Wang, X. Li, G. Ning, The association of serum chemerin level with risk of coronary artery disease in Chinese adults. Endocrine 41(2), 281-288 (2012)